genotype 1

November 29, 2016November 29, 2016

Gilead Sciences Canada Recognized for Developing Harvoni as Hepatitis C Therapy

Hepatitis C, News

Gilead Sciences Canada has been awarded this year’s Prix Galien Canada–Innovative Product Award for the development of Harvoni (ledipasvir/sofosbuvir), a once-daily combination pill for the treatment of chronic genotype 1 hepatitis ... Read more

January 28, 2015January 28, 2015

Hepatitis C Treatment VIEKIRAX® + EXVIERA® Now EMA-Approved

News

The European Commission has granted marketing authorizations for AbbVie’s all-oral, interferon-free, short-course treatment with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets). This treatment was recently approved with or without ribavirin (RBV) for patients suffering ... Read more

October 20, 2014October 20, 2014

New Oral Drugs Show Promise as Hepatitis C Cure

Hepatitis C, News

A pair of highly promising drug study results are scheduled to be presented during the 22nd United European Gastroenterology Week (UEG Week 2014), which began in Vienna, Austria on Saturday, October 18. The conference will ... Read more